Manage episode 509040572 series 2931422
With numerous new medications launching each year, pharmacists play a vital role in translating complex drug information into practical, patient-centered care. This episode offers a brief overview of select FDA-approved drugs from the past year, highlighting their therapeutic importance, key considerations, and clinical uses. Whether counseling patients or working with healthcare providers, pharmacists need to stay informed about what’s new—and understand its impact on practice.
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Joe Strain, PharmD
Professor of Pharmacy Practice
South Dakota State University/Monument Health Rapid City Hospital
Joshua Davis Kinsey and Joe Strain have no relevant financial relationships to disclose.
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
- If you are already enrolled in this course, click here to redeem your credit.
- To purchase this episode and claim your CPE credit, click here.
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List unique pharmacological properties for select newly approved medications.
2. Recognize important safety considerations, including adverse effects, interactions, and monitoring parameters, for each featured drug.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-295-H01-P
Initial release date: 9/29/2025
Expiration date: 9/29/2026
Additional CPE details can be found here.
Chapters
1. Introduction to New Medication Updates (00:00:00)
2. New Antibiotics for UTIs (00:04:14)
3. Novel Mechanism for Schizophrenia Treatment (00:12:30)
4. Non-Opioid Pain Management Option (00:22:55)
5. Topical Treatment for Molluscum Contagiosum (00:31:17)
6. Oral Option for Dialysis-Related Anemia (00:36:15)
7. New Approach for Dry Eye Disease (00:41:12)
8. Key Takeaways and Conclusion (00:45:06)
365 episodes